BANCR: A Potential Drug Target and Biomarker (G100885775)

Target Name: BANCR

NCBI ID: G100885775

BANCR

Other Name(s): BRAF-activated non-protein coding RNA | LINC00586

BANCR: A Potential Drug Target and Biomarker

BanCR, short for brain-associated neurotrophic factor receptor, is a protein that is expressed in various tissues of the brain, including the cerebral cortical cortical and subcortical regions. It is a member of the neurotrophic factor receptor family, which includes several other proteins, including NT-3, NT-4, and NT-5. The neurotrophic factor receptor family plays a crucial role in the survival and function of neurons and has been implicated in various neurological disorders, including Alzheimer's disease, Parkinson's disease, and depression.

BanCR has been identified as a potential drug target due to its involvement in the regulation of neuronal excitability and its role in the development and progression of neurological disorders. Several studies have shown that BanCR plays a role in the regulation of neurotransmitter release and that its activity can be modulated by various drug treatments. For example, inhibition of BanCR has been shown to protect neurons from the neurotoxicity of various drugs, including neuroblastoma, glutamate excitotoxicity, and hypoxic stress.

In addition to its potential as a drug target, BanCR has also been identified as a potential biomarker for certain neurological disorders. The levels of BanCR have been shown to be altered in various neurological disorders, including Alzheimer's disease, Parkinson's disease, and depression. Additionally, some studies have shown that BanCR levels are also altered in neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. These findings suggest that BanCR may be a useful biomarker for the diagnosis and treatment of certain neurological disorders.

The identification of BanCR as a potential drug target and biomarker has important implications for the development of new treatments for neurological disorders. By targeting BanCR, researchers may be able to improve the function of the brain and slow the progression of neurodegenerative diseases. Additionally, BanCR may also be a useful target for drug development in other areas, such as neuroscience research, where the study of neurotrophic factors and their receptors is an active area of study.

In conclusion, BanCR is a protein that has been identified as a potential drug target and biomarker for the regulation of neuronal excitability and the development and progression of neurological disorders. Further research is needed to fully understand the role of BanCR in these processes and to develop new treatments for neurological disorders. However, the potential of BanCR as a drug target and biomarker is an exciting area of research that has the potential to improve the lives of many people.

Protein Name: BRAF-activated Non-protein Coding RNA

The "BANCR Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BANCR comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets